ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma hikes investment in US-based eGenesis to .7 million
Natco Pharma Ltd on Monday said it has decided to increase its proposed investment in US-based biotechnology firm eGenesis Inc to USD 16.70 million (around Rs 139 crore) from the previously disclosed amount of USD 14 million. Under the revised structure, N
Announcement as on 29 September 2026

Natco Pharma to invest mn in US-based biotechnology firm eGenesis Inc
Natco Pharma on Tuesday said it is investing USD 14 million (over Rs 130 crore) in eGenesis Inc, a US-based biotechnology firm, through its two subsidiaries. As part of the transaction, Natco Pharma (Canada) Inc will invest USD 9.5 million and Natco Pharma
Announcement as on 25 August 2026

Natco Pharma Q1 results: Profit falls 57% to ?206 cr, revenue at ?735 cr
Natco Pharma Ltd on Friday reported a 57 per cent decline in consolidated net profit at Rs 206.5 crore in the first quarter ended June 2026, hit by lower sales of its generic cancer treatment drug lenalidomide. The company had posted a consolidated net pro
Announcement as on 14 August 2026

Natco Pharma Q1 profit falls 57 pc to Rs 206.5 cr
Natco Pharma has reported a stark profit decline in the first quarter, largely driven by reduced sales of its leading cancer drug, lenalidomide. This led to a pronounced drop in consolidated revenues compared to the prior year. On a brighter note, the core
Announcement as on 14 August 2026

Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoY
Natco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins and lower annual earnings weighed on investor sentiment despite a one-time tax-related benefit recorded during the quar
Announcement as on 29 May 2026

Announcements by Natco Pharm first page | Next page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 827.93
  • 12Day Average: 826.96
  • 20Day Average: 825.49
  • 50Day Average: 867.64
  • 100Day Average: 924.56
  • 150Day Average: 961.87
  • 200Day Average: 939.95

524816 Indicators & signals

Indicator MACD (12,26,9)

828.35, 838.7, -13.62
Indicator MACD is in negative zone

Indicator ADX (14)

23.34, 12.25, 19.7
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Tue Oct 2026 823.70 815.55 to 826.00 0.19% 0.73 times
05 Mon Oct 2026 822.15 801.35 to 827.65 0.05% 1.03 times
01 Thu Oct 2026 821.75 803.30 to 826.75 -2.63% 0.75 times
29 Tue Sep 2026 843.95 827.90 to 851.65 1.91% 0.81 times
28 Mon Sep 2026 828.10 824.00 to 856.30 -1.42% 1.8 times
25 Fri Sep 2026 840.05 835.00 to 850.20 -0.21% 0.52 times
24 Thu Sep 2026 841.85 831.15 to 855.00 0.48% 1.89 times
23 Wed Sep 2026 837.85 811.90 to 840.00 2.81% 0.61 times
22 Tue Sep 2026 814.95 806.30 to 820.00 -0.19% 0.9 times
21 Mon Sep 2026 816.50 806.10 to 818.45 0.32% 0.8 times
18 Fri Sep 2026 813.90 807.00 to 821.85 -0.59% 0.9 times
17 Thu Sep 2026 818.75 805.90 to 820.10 0.68% 0.3 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top